Inflammation versus immunoregulation: what is the key to the development of an effective antiallergy vaccine?
The incidence and severity of allergic disorders is currently increasing worldwide. The reason for this development is unclear. However, epidemiological studies and experimental data suggest that this increase may be due to a decline in infectious diseases which induce T helper type 1 (Th1) and/or T regulatory (Tr) responses. Based on these observations, antiallergy vaccines are currently being tested in animal studies aimed at inducing Th1 or Tr responses. This review focuses on novel approaches potentially leading to a vaccine protecting humans from the development of allergic disorders.
Wohlleben
G
G
Center for Infectious Diseases, University of Würzburg, Würzburg, Germany.
Erb
K J
KJ
D000485:Allergens / Q000276:immunology*; D000818:Animals; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000517:prevention & control; D007114:Immunization; D007249:Inflammation / Q000276:immunology*; D014612:Vaccines / Q000276:immunology*
D000485:Allergens; D014612:Vaccines